SC
AZN icon

Savant Capital’s AstraZeneca AZN Stock Holding History

Savant Capital’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.83M Buy
35,321
+25,996
+279% +$4.89M 0.02% 383
2026
Q1 		$1.84M Buy
9,325
+393
+4% +$75.8K 0.01% 446
2025
Q4 		$1.64M Sell
8,932
-671
-7% -$118K 0.01% 443
2025
Q3 		$1.47M Sell
9,603
-233
-2% -$35.3K 0.01% 458
2025
Q2 		$1.37M Buy
9,836
+3,605
+58% +$505K 0.01% 437
2025
Q1 		$916K Sell
6,231
-16,682
-73% -$2.41M 0.01% 505
2024
Q4 		$3M Buy
22,913
+563
+3% +$78.8K 0.02% 328
2024
Q3 		$3.48M Buy
22,350
+2,063
+10% +$333K 0.03% 290
2024
Q2 		$3.16M Sell
20,287
-580
-3% -$87.3K 0.03% 273
2024
Q1 		$2.83M Sell
20,867
-158
-0.8% -$20.9K 0.03% 275
2023
Q4 		$2.83M Sell
21,025
-251
-1% -$32.6K 0.04% 230
2023
Q3 		$2.88M Sell
21,276
-254
-1% -$34.7K 0.04% 219
2023
Q2 		$3.08M Buy
21,530
+19,771
+1,124% +$2.91M 0.05% 213
2023
Q1 		$244K Buy
+1,759
New +$237K ﹤0.01% 643
2016
Q2 		– Sell
-3,907
Closed -$220K – 252
2016
Q1 		$220K Buy
+3,907
New +$235K 0.07% 206

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Savant Capital's AZN Position: Q2 2026 in Review

Savant Capital increased its AstraZeneca (AZN) stake by 279% in Q2 2026, buying an estimated $4.89M and bringing the position to 35,321 shares worth $5.83M. The position accounts for 0.02% of the portfolio, ranked #383.

Savant Capital first reported a position in AZN in Q1 2016 and has held it in 15 quarters since. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Savant Capital held 35,321 shares of AstraZeneca worth $5.83M as of Q2 2026.
  • Savant Capital bought 25,996 AstraZeneca shares in Q2 2026, an estimated $4.89M.
  • AstraZeneca made up 0.02% of Savant Capital's portfolio in Q2 2026, its #383 holding.
  • Savant Capital first reported a position in AstraZeneca in Q1 2016 and has held it in 15 quarters since.
  • 1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Savant Capital's 13F filing for Q2 2026, filed 10 Aug 2026.